183 related articles for article (PubMed ID: 31907357)
21. Characteristics of in vivo murine erythropoietic response to sodium orthovanadate.
Aguirre MV; Juaristi JA; Alvarez MA; Brandan NC
Chem Biol Interact; 2005 Sep; 156(1):55-68. PubMed ID: 16137666
[TBL] [Abstract][Full Text] [Related]
22. Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199.
García CP; Videla Richardson GA; Dimopoulos NA; Fernandez Espinosa DD; Miriuka SG; Sevlever GE; Romorini L; Scassa ME
PLoS One; 2016; 11(3):e0152607. PubMed ID: 27030982
[TBL] [Abstract][Full Text] [Related]
23. Endothelial Cell-Selective Adhesion Molecule Expression in Hematopoietic Stem/Progenitor Cells Is Essential for Erythropoiesis Recovery after Bone Marrow Injury.
Sudo T; Yokota T; Okuzaki D; Ueda T; Ichii M; Ishibashi T; Isono T; Habuchi Y; Oritani K; Kanakura Y
PLoS One; 2016; 11(4):e0154189. PubMed ID: 27111450
[TBL] [Abstract][Full Text] [Related]
24. Mcl-1 and Bcl-xL are essential for survival of the developing nervous system.
Fogarty LC; Flemmer RT; Geizer BA; Licursi M; Karunanithy A; Opferman JT; Hirasawa K; Vanderluit JL
Cell Death Differ; 2019 Aug; 26(8):1501-1515. PubMed ID: 30361616
[TBL] [Abstract][Full Text] [Related]
25. Side-by-side comparison of BH3-mimetics identifies MCL-1 as a key therapeutic target in AML.
Ewald L; Dittmann J; Vogler M; Fulda S
Cell Death Dis; 2019 Dec; 10(12):917. PubMed ID: 31801941
[TBL] [Abstract][Full Text] [Related]
26. Anti-apoptotic Bcl-XL but not Mcl-1 contributes to protection against virus-induced apoptosis.
Ohmer M; Weber A; Sutter G; Ehrhardt K; Zimmermann A; Häcker G
Cell Death Dis; 2016 Aug; 7(8):e2340. PubMed ID: 27537523
[TBL] [Abstract][Full Text] [Related]
27. Expression of Bcl-x in erythroid precursors from patients with polycythemia vera.
Silva M; Richard C; Benito A; Sanz C; Olalla I; Fernández-Luna JL
N Engl J Med; 1998 Feb; 338(9):564-71. PubMed ID: 9475763
[TBL] [Abstract][Full Text] [Related]
28. Caspase-3-dependent cleavage of Bcl-xL in the stroma exosomes is required for their uptake by hematological malignant cells.
Vardaki I; Sanchez C; Fonseca P; Olsson M; Chioureas D; Rassidakis G; Ullén A; Zhivotovsky B; Björkholm M; Panaretakis T
Blood; 2016 Dec; 128(23):2655-2665. PubMed ID: 27742710
[TBL] [Abstract][Full Text] [Related]
29. CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.
Gress V; Roussy M; Boulianne L; Bilodeau M; Cardin S; El-Hachem N; Lisi V; Khakipoor B; Rouette A; Farah A; Théret L; Aubert L; Fatima F; Audemard É; Thibault P; Bonneil É; Chagraoui J; Laramée L; Gendron P; Jouan L; Jammali S; Paré B; Simpson SM; Tran TH; Duval M; Teira P; Bittencourt H; Santiago R; Barabé F; Sauvageau G; Smith MA; Hébert J; Roux PP; Gruber TA; Lavallée VP; Wilhelm BT; Cellot S
Blood Adv; 2024 Jan; 8(1):112-129. PubMed ID: 37729615
[TBL] [Abstract][Full Text] [Related]
30. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
[TBL] [Abstract][Full Text] [Related]
31. Mcl-1 and Bcl-x
Hockings C; Alsop AE; Fennell SC; Lee EF; Fairlie WD; Dewson G; Kluck RM
Cell Death Differ; 2018 Mar; 25(4):721-734. PubMed ID: 29459767
[TBL] [Abstract][Full Text] [Related]
32. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice.
Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S
Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795
[TBL] [Abstract][Full Text] [Related]
33. Diamond blackfan anemia stem cells fail to repopulate erythropoiesis in NOD/SCID mice.
Zivny J; Jelinek J; Pospisilova D; Plasilova M; Necas E; Stopka T
Blood Cells Mol Dis; 2003; 31(1):93-7. PubMed ID: 12850491
[TBL] [Abstract][Full Text] [Related]
34. Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation.
Kollek M; Voigt G; Molnar C; Murad F; Bertele D; Krombholz CF; Bohler S; Labi V; Schiller S; Kunze M; Geley S; Niemeyer CM; Garcia-Saez A; Erlacher M
J Exp Med; 2017 Oct; 214(10):2967-2983. PubMed ID: 28882984
[TBL] [Abstract][Full Text] [Related]
35. Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma.
Tanos R; Karmali D; Nalluri S; Goldsmith KC
BMC Cancer; 2016 Feb; 16():97. PubMed ID: 26874859
[TBL] [Abstract][Full Text] [Related]
36. BCL-2 is dispensable for thrombopoiesis and platelet survival.
Debrincat MA; Pleines I; Lebois M; Lane RM; Holmes ML; Corbin J; Vandenberg CJ; Alexander WS; Ng AP; Strasser A; Bouillet P; Sola-Visner M; Kile BT; Josefsson EC
Cell Death Dis; 2015 Apr; 6(4):e1721. PubMed ID: 25880088
[TBL] [Abstract][Full Text] [Related]
37. Safety and Efficacy of Megakaryocytes Induced from Hematopoietic Stem Cells in Murine and Nonhuman Primate Models.
Guan X; Qin M; Zhang Y; Wang Y; Shen B; Ren Z; Ding X; Dai W; Jiang Y
Stem Cells Transl Med; 2017 Mar; 6(3):897-909. PubMed ID: 28297572
[TBL] [Abstract][Full Text] [Related]
38. Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells.
Xie Y; Koch ML; Zhang X; Hamblen MJ; Godinho FJ; Fujiwara Y; Xie H; Klusmann JH; Orkin SH; Li Z
Stem Cells; 2017 Jul; 35(7):1773-1785. PubMed ID: 28436588
[TBL] [Abstract][Full Text] [Related]
39. BCL-XL exerts a protective role against anemia caused by radiation-induced kidney damage.
Brinkmann K; Waring P; Glaser SP; Wimmer V; Cottle DL; Tham MS; Nhu D; Whitehead L; Delbridge AR; Lessene G; Smyth IM; Herold MJ; Kelly GL; Grabow S; Strasser A
EMBO J; 2020 Dec; 39(24):e105561. PubMed ID: 33236795
[TBL] [Abstract][Full Text] [Related]
40. Loss of ASXL1 triggers an apoptotic response in human hematopoietic stem and progenitor cells.
Hilgendorf S; Folkerts H; Schuringa JJ; Vellenga E
Exp Hematol; 2016 Dec; 44(12):1188-1196.e6. PubMed ID: 27616637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]